The clinical features and outcome of 2009 H1N1 influenza infection in allo-SCT patients: a British Society of Blood and Marrow Transplantation study

Bone Marrow Transplant. 2012 Jan;47(1):88-94. doi: 10.1038/bmt.2011.12. Epub 2011 Feb 28.

Abstract

The clinical course of 2009 H1N1 influenza in Allo-SCT patients is unknown. Data were collected in the UK from October 2009 to April 2010 on laboratory-confirmed cases of H1N1 influenza in Allo-SCT recipients. H1N1 infection was diagnosed in 60 patients, median age 42 years, at a median of 10 months post-SCT. Twenty-one patients (35%) developed pneumonia and nine (15%) required admission to intensive care units. Actuarial mortality was 7% at 28 days and 19% 4 months post-diagnosis of 2009 H1N1 influenza. Increasing age and pre-existing lung disease were risk factors for pneumonia (P=0.006 and 0.037, respectively); older age was a risk factor for death (P=0.012). Morbidity and mortality from 2009 H1N1 influenza in SCT patients exceeds that of immunocompetent patients, but parallels that in other critically ill hospitalised cohorts; the elderly and those with chronic pulmonary disease are at greatest risk.

Publication types

  • Clinical Trial
  • Multicenter Study

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Bone Marrow Transplantation
  • Child
  • Child, Preschool
  • Cohort Studies
  • Critical Care
  • Disease-Free Survival
  • Female
  • Humans
  • Infant
  • Influenza A Virus, H1N1 Subtype*
  • Influenza, Human / mortality*
  • Influenza, Human / therapy
  • Male
  • Middle Aged
  • Pandemics*
  • Pneumonia / mortality*
  • Pneumonia / therapy
  • Societies, Medical
  • Stem Cell Transplantation*
  • Survival Rate
  • Time Factors
  • Transplantation, Homologous
  • United Kingdom / epidemiology